You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Mafenide acetate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for mafenide acetate and what is the scope of patent protection?

Mafenide acetate is the generic ingredient in two branded drugs marketed by Rising, Novast Labs, Par Form, and Mylan Institutional, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for mafenide acetate. Three suppliers are listed for this compound.

Drug Prices for mafenide acetate

See drug prices for mafenide acetate

Recent Clinical Trials for mafenide acetate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Valleywise HealthN/A
Maricopa Integrated Health SystemN/A
PuriCore, Inc.N/A

See all mafenide acetate clinical trials

Pharmacology for mafenide acetate
Medical Subject Heading (MeSH) Categories for mafenide acetate

US Patents and Regulatory Information for mafenide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rising SULFAMYLON mafenide acetate CREAM;TOPICAL 016763-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Par Form MAFENIDE ACETATE mafenide acetate FOR SOLUTION;TOPICAL 201511-001 Feb 12, 2013 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan Institutional SULFAMYLON mafenide acetate FOR SOLUTION;TOPICAL 019832-003 Jun 5, 1998 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novast Labs MAFENIDE ACETATE mafenide acetate FOR SOLUTION;TOPICAL 206716-001 Jul 31, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.